Effectiveness of Mabthera in advanced stages B-CLL and for in vivo purging autologous peripheral stem cell transplantation.

被引：0
|
作者：
Shtalrid, M [1 ]
Shvidel, L [1 ]
Klepfish, A [1 ]
Haran, M [1 ]
Berrebi, A [1 ]
机构：
[1] Kaplan Med Ctr, Inst Hematol, Rehovot, Israel
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4916
引用
收藏
页码：293B / 293B
页数：1
相关论文
共 50 条
  • [31] Significative low incidence of hepatic VOD in autologous peripheral blood stem cell (PBSC) Transplantation.
    Feldman, LJ
    Requejo, A
    Milovic, V
    Jaimovich, G
    Brioschi, S
    Listello, V
    Puente, D
    Burgos, R
    BLOOD, 2002, 100 (11) : 425B - 425B
  • [32] In vitro and in vivo cytotoxicity of fludarabine in patients with advanced stage B-cell chronic lymphocytic leukemia (B-CLL)
    Hilgenfeld, E
    Knauf, WU
    Thiel, E
    DRUG RESISTANCE IN LEUKEMIA AND LYMPHOMA II, 1997, 3 : 245 - 253
  • [33] Efficacy of ex vivo purging with CD34+selection to maximize the effects of autologous stem cell transplantation in peripheral T-cell lymphoma patients
    Jeon, Youngwoo
    Kim, Tong-Yoon
    Min, Gi June
    Park, Sung-Soo
    Park, Silvia
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Kim, Hee-Je
    Lee, Seok
    Min, Chang-Ki
    Lee, Jong-Wook
    Cho, Seok-Goo
    CYTOTHERAPY, 2023, 25 (12) : 1307 - 1316
  • [34] The effectiveness of darbepoetin alfa in patients undergoing autologous stem cell transplantation. Single institution experience
    Gonzalez Sierra, P.
    Almagro Torres, F.
    Martinez Quesada, M. J.
    Trujillo Perez, M. M.
    Lopez Lopez, J. A.
    Luque Ortega, P.
    Duran Nieto, S.
    Carrero Gonzalez, A.
    Alcala Munoz, A.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S85 - S86
  • [35] Autologous peripheral blood stem cell transplantation in patient in advanced stage of POEMS syndrome
    Cioch, M.
    Manko, J.
    Dmoszynska, A.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S153 - S153
  • [36] Immune reconstitution after allogeneic stem cell transplantation (aSCT) in patients with B-CLL correlates with the administration of campath
    Oelschlaegel, U.
    Thiede, C.
    Bornhaeuser, M.
    Geissler, G.
    Baurmann, H.
    Ehninger, G.
    Schetelig, J.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S69 - S70
  • [37] Clinical significance of autologous hematopoietic stem cell transplantation with ex vivo purging using clinimacs in T-cell lymphomas
    Cho, Seok-Goo
    Jeon, Young-Woo
    Yoon, Seugyun
    Min, Gi June
    Park, Sung-Soo
    Park, Silvia
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Kim, Hee-Je
    Lee, Seok
    Min, Chang-Ki
    Lee, Jong-Wook
    BONE MARROW TRANSPLANTATION, 2019, 54 : 461 - 461
  • [38] Peripheral blood stem cell mobilisation in lymphoma patients candidates to autologous transplantation. Development of a predictive score
    Rossi, G.
    Skert, C.
    Morello, E.
    Almici, C.
    Arcaini, L.
    Basilico, C.
    Botto, B.
    Castelli, A.
    Pica, G.
    Ripamonti, F.
    Salvi, F.
    Carella, A. M.
    Gaidano, G.
    Levis, A.
    Nosari, A.
    Russo, D.
    Vitolo, U.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S22 - S22
  • [39] The aspect of quality of life (QL) in lymphoma patients treated by autologous peripheral blood stem cell transplantation.
    Langenmayer, I
    Jäger, HD
    Bründl, M
    Bullinger, M
    Adler, S
    Straka, C
    Christgau, H
    Beyer, C
    Oduncu, F
    Emmerich, B
    BLOOD, 1998, 92 (10) : 344B - 344B
  • [40] Efficiency of in vivo purging with rituximab followed by high-dose therapy (HDT) with autologous peripheral blood stem cell transplantation (PBSCT) in B-cell lymphomas. A single center study
    Belhadj, K
    Delfau-Larue, MH
    Elgnaoui, T
    Beaujean, F
    Beaumont, JL
    Pautas, C
    Gaillard, I
    Kirova, Y
    Allain, A
    Gaulard, P
    Farcet, JP
    Reyes, F
    Haioun, C
    BONE MARROW TRANSPLANTATION, 2002, 29 : S89 - S89
12345